China Artificial Organs & Bionic Implants Market - Growth, Trends & Forecast (2017 - 2022)

The UK's contraceptive devices market accounted for a market size of USD XX billion in 2016 and is expected to reach USD XX billion by 2021, growing at a CAGR of XX%.

UK Contraceptive Devices Market-Market Dynamics

The report details several factors driving and restraining the market, some of which are listed below.


Product innovations
Increasing incidence of STDs
Pregnancy prevention
Increasing government initiatives for abortion
Increasing awareness amongst people

Infertility issues and fear or experience of side-effects are factors turning out to be restraints to this market.

The UK's contraceptive devices market has been segmented based on contraceptive methods, mode of delivery and type of device. The segmentation on contraceptive methods has been subdivided into sterilization, pills, implants, injectables, IUD, male condoms, vaginal barrier methods and others. The segmentation based on the mode of delivery has been sub-divided into oral contraceptives, topical contraceptives, and contraceptive injectables. The segmentation based on the type of device has been sub-divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, IUD, and implants.

The intrauterine devices (IUD) segment has the largest market share in the UK. There is also a sustained growth of sub-dermal implants in the UK's market.

Some of the key players in the market are:

Actavis Inc.
Agile Therapeutics
Bayer Healthcare
Fuji Latex
Merck & Co. Inc.
Reckitt Benckiser PLC
Teva Pharmaceuticals
Key Deliverables of the Study

Market definition along with identification of key drivers and restraints for the market.
Market analysis for the UK's contraceptive devices market, with region-specific assessments and competition analysis.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the UK's contraceptive devices market on a regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

1. Introduction

1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast Period Years

1.6 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Model

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

5.1 Current Market Scenario

5.2 Contraceptive Devices Applications

5.3 Technology Overview

5.4 New Developments

5.5 Industry Value Chain Analysis

5.6 Product Life Cycle Analysis

5.7 Product Benchmarking

5.8 Investment Analysis

5.9 Porter's Five Forces

5.9.1 Bargaining Power of Suppliers

5.9.2 Bargaining Power of Consumers

5.9.3 Threat to New Entrants

5.9.4 Threat to Substitute Products and Services

5.9.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis

6.1 Market Drivers

6.1.1 Product Innovation

6.1.2 Increasing Incidence of STDs

6.1.3 Pregnancy Prevention

6.1.4 Increasing Government Initiatives for Unwanted Abortion

6.1.5 Increasing Awareness amongst People

6.2 Market Restraints

6.2.1 Infertility Issues

6.2.2 Fear or Experience of Side Effects

7. UK Contraceptive Devices Market Segmentation

7.1 Introduction

7.2 By Contraceptive Methods

7.2.1 Sterilization

7.2.2 Pills

7.2.3 Implants

7.2.4 Injectable

7.2.5 Intrauterine Device

7.2.6 Male Condoms

7.2.7 Vaginal Barrier Methods

7.2.8 Others

7.3 By Mode of Delivery

7.3.1 Oral Contraceptives Combined Oral Contraceptive Pills Progestin-Only Pill Emergency Contraceptive Pill

7.3.2 Topical Contraceptives

7.3.3 Contraceptive Injectables

7.4 By Type of Device

7.4.1 Condoms

7.4.2 Diaphragms

7.4.3 Cervical Caps

7.4.4 Sponges

7.4.5 Vaginal Rings

7.4.6 IUD

7.4.7 Implants

8. Market Segmentation by Geography - the UK

8.1 Introduction

8.2 United Kingdom Market

9. Competitive Landscape

9.1 Merger and Acquisition Analysis

9.2 New Product Launches

9.3 Agreements, Collaborations, and Partnerships

10. Key Vendor Analysis

10.1 Church & Dwight, Co. Inc.

10.2 Reckitt Benckiser PLC

10.3 Bayer healthcare

10.4 Teva Pharmaceuticals

10.5 Pfizer

10.6 Fuji Latex

10.7 Actavis Inc.

10.8 Merck & Co. Inc.

10.9 Agile Therapeutics

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

Content are not available

Choose License Type